The Molecular Diagnostics Market is witnessing remarkable growth, driven by increasing bacterial and viral epidemics, a growing demand for point-of-care diagnostics, and recent advancements in pharmacogenomics. This article aims to provide an in-depth analysis of the market drivers and challenges, highlighting the opportunities and obstacles faced by businesses, decision-makers, investors, and R&D professionals in this rapidly evolving industry. DataM Intelligence provides a thorough understanding of the market size, market growth, market share, and market trends essential for the success of any business in this sector.
Market Size and Growth – The Impact of Epidemics
The large outbreaks of bacterial and viral epidemics worldwide have significantly contributed to the growth of the molecular diagnostics market. For example, according to a 2019 report on HIV outcomes, approximately 86,000 people in Germany lived with HIV, with approximately 20% residing in Berlin.
Additionally, the British Heart Foundation estimated that around 7 million people were living with heart and circulatory diseases in the United Kingdom in 2018, with healthcare costs relating to these conditions amounting to around GBP 9 billion annually. Consequently, the burden of chronic diseases is expected to increase the adoption of molecular diagnostics.
Market Share – Expansion and Collaboration Strategies
The immense opportunity for in vitro diagnostics has encouraged many market players to adopt various strategies such as collaborations, acquisitions, new product launches, and expansions into the Asia Pacific market. For instance, in January 2020, Illumina received product approval from Pharmaceuticals and Medical Devices Agency (PMDA), Japan, for its MiSeqDx instrument. This approval enabled the distribution of MiSeqDx as a Class I medical device in Japan, positively impacting the market.
Moreover, in September 2018, Biocartis Group NV, an innovative molecular diagnostics company, and Guangzhou Wondfo Biotech Co. Ltd, a fast-growing diagnostics leader in China, entered a joint venture aimed at commercializing the fully automated molecular diagnostics Idylla platform in mainland China, within the oncology field. These strategic moves are expected to drive market growth over the forecast period.
Market Analysis – Point-of-Care Diagnostics and Pharmacogenomics
The increasing demand for point-of-care diagnostics and advancements in pharmacogenomics is also expected to propel the molecular diagnostics market forward. Point-of-care diagnostics allow for rapid, accurate, and cost-effective testing, enabling healthcare providers to make quick and informed decisions.
On the other hand, pharmacogenomics aims to understand how an individual's genetic makeup affects their response to medications, thereby promoting personalized medicine and improving patient outcomes.
Market Drivers and Challenges – The High Cost of Molecular Diagnostics
Despite its numerous advantages, molecular diagnostics also face challenges, primarily the high cost of these technologies. Molecular diagnostics are generally more expensive than traditional methodologies, with equipment and reagent costs possibly prohibitive for some laboratories.
As molecular methods become more widespread, costs could potentially decrease. However, laboratories that find the cost prohibitive often prefer transporting molecular specimens to a reference laboratory. These factors may hamper the market growth in the forecast period.
Future of Molecular Diagnostics Market with Market Drivers and Challenges
The molecular diagnostics market is poised for significant growth, driven by the increasing burden of bacterial and viral epidemics, the growing demand for point-of-care diagnostics, and recent advancements in pharmacogenomics. However, the high cost of molecular diagnostics may present challenges for market growth. To understand the market dynamics comprehensively and capitalize on the opportunities available, businesses, investors, and professionals in this sector must stay informed and adapt to the ever-changing landscape.
DataM Intelligence offers a detailed market analysis to assist you in making informed decisions and staying ahead of the competition. Request a sample report on the molecular diagnostics market by visiting our download-sample page.
For More Insights About the Market Request Free Sample
